Suppression of protein tyrosine phosphatase PTPN22 gene induces apoptosis in T-cell leukemia cell line (Jurkat) through the AKT and ERK pathways

详细信息    查看全文

• 作者：Elham Baghbani^a ; ^b ; Behzad Baradaran^b ; Fatemeh Pak^a ; Leila Mohammadnejad^b ; Daryoush Shanehbandi^b ; Behzad Mansoori^b ; Vahid Khaze^b ; Noushin Montazami^b ; Ali Mohammadi^b ; Parviz Kokhaei^c ; ^d ; ^{Parviz.kokhaei@ki.se}
• 关键词：Protein tyrosine phosphatase non-receptor type 22 ; siRNA ; Jurkat ; Apoptosis ; AKT ; ERK ; T-cell leukemia
• 刊名：Biomedicine & Pharmacotherapy
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：86
• 期：Complete
• 页码：41-47
• 全文大小：1498 K
• 卷排序：86

文摘

The aim of this study was to investigate the effect of specific PTPN22 small interfering RNAs (siRNAs) on the viability and induction of apoptosis in Jurkat cells and to evaluate apoptosis signaling pathways. In this study, Jurkat cells were transfected with specific PTPN22 siRNA. Relative PTPN22 mRNA expression was measured by Quantitative Real-time PCR. Western blotting was performed to determine the protein levels of PTPN22, AKT, P-AKT, ERK, and P-ERK. The cytotoxic effects of PTPN22 siRNA were determined using the MTT assay. Apoptosis was quantified using TUNEL assay and flow cytometry. Results showed that in Jurkat cells after transfection with PTPN22 siRNA, the expression of PTPN22 in both mRNA and protein levels was effectively reduced. Moreover, siRNA transfection induced apoptosis on the viability of T-cell acute leukemia cells. More importantly, PTPN22 positively regulated the anti-apoptotic AKT kinase, which provides a powerful survival signal to T-ALL cells as well as the suppression of PTPN22 down regulated ERK activity. Our results suggest that the PTPN22 specific siRNA effectively decreases the viability of T-cell acute leukemia cells, induces apoptosis in this cell line, and therefore could be considered as a potent adjuvant in T-ALL therapy.